The ClearSky Medical Diagnostics team will be attending the 23rd International Congress of Parkinson’s Disease and Movement Disorders (MDS) in September.
The Congress brings together global experts on neurodegenerative and neurodevelopmental disorders, including Parkinson’s, hyperkinetic movement disorders and abnormalities in muscle tone and motor control.
This year’s Congress takes place at the Nice Acropolis Convention Centre from 22 to 26 September 2019 with the theme ‘Translating the Science of Movement Disorders into Clinical Practice’.
Professor Stephen Smith, our Co-Founder and Managing Director, will be joined by Director Betty Su, Alex Lou, Director of Global Business Development, and Director Harvey Dettmar at the Congress. Meet the team at Stand 10 in the Exhibit Hall of the Nice Acropolis Convention Centre.
If you would like to chat about our technology for diagnosing and monitoring neurodegenerative conditions, including Parkinson’s and Alzheimer’s, please get in touch.